Monoclonal Antibody

From Proteopedia

(Redirected from Monoclonal antibodies)
Jump to: navigation, search

Mouse monoclonal antibody matuzumab light chain (aqua) and heavy chain (red) complex with sulfate (PDB code 3c08)

Drag the structure with the mouse to rotate


  1. 1.0 1.1 Roit, I. M. Roit's Essential Immunology. Oxford: Blackwell Science Ltd., 1997.
  2. Ghosh AK, Spriggs AI, Taylor-Papadimitriou J, Mason DY. Immunocytochemical staining of cells in pleural and peritoneal effusions with a panel of monoclonal antibodies. J Clin Pathol. 1983 Oct;36(10):1154-64. PMID:6194183
  3. Klee GG. Human anti-mouse antibodies. Arch Pathol Lab Med. 2000 Jun;124(6):921-3. PMID:10835540
  4. Goldstein NI, Prewett M, Zuklys K, Rockwell P, Mendelsohn J. Biological efficacy of a chimeric antibody to the epidermal growth factor receptor in a human tumor xenograft model. Clin Cancer Res. 1995 Nov;1(11):1311-8. PMID:9815926
  5. Brady RL, Edwards DJ, Hubbard RE, Jiang JS, Lange G, Roberts SM, Todd RJ, Adair JR, Emtage JS, King DJ, et al.. Crystal structure of a chimeric Fab' fragment of an antibody binding tumour cells. J Mol Biol. 1992 Sep 5;227(1):253-64. PMID:1522589
  6. Riechmann L, Clark M, Waldmann H, Winter G. Reshaping human antibodies for therapy. Nature. 1988 Mar 24;332(6162):323-7. PMID:3127726 doi:
  7. Barbas CF 3rd, Kang AS, Lerner RA, Benkovic SJ. Assembly of combinatorial antibody libraries on phage surfaces: the gene III site. Proc Natl Acad Sci U S A. 1991 Sep 15;88(18):7978-82. PMID:1896445
  8. Smith GP. Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface. Science. 1985 Jun 14;228(4705):1315-7. PMID:4001944
  9. Wurm FM. Production of recombinant protein therapeutics in cultivated mammalian cells. Nat Biotechnol. 2004 Nov;22(11):1393-8. PMID:15529164 doi:10.1038/nbt1026
  10. Choi BK, Bobrowicz P, Davidson RC, Hamilton SR, Kung DH, Li H, Miele RG, Nett JH, Wildt S, Gerngross TU. Use of combinatorial genetic libraries to humanize N-linked glycosylation in the yeast Pichia pastoris. Proc Natl Acad Sci U S A. 2003 Apr 29;100(9):5022-7. Epub 2003 Apr 17. PMID:12702754 doi:10.1073/pnas.0931263100
  11. van der Kolk LE, Baars JW, Prins MH, van Oers MH. Rituximab treatment results in impaired secondary humoral immune responsiveness. Blood. 2002 Sep 15;100(6):2257-9. PMID:12200395
  12. Jacene HA, Filice R, Kasecamp W, Wahl RL. Comparison of 90Y-ibritumomab tiuxetan and 131I-tositumomab in clinical practice. J Nucl Med. 2007 Nov;48(11):1767-76. Epub 2007 Oct 17. PMID:17942813 doi:10.2967/jnumed.107.043489
  13. Bagshawe KD. Antibody-directed enzyme prodrug therapy (ADEPT) for cancer. Expert Rev Anticancer Ther. 2006 Oct;6(10):1421-31. PMID:17069527 doi:10.1586/14737140.6.10.1421
  14. Xu G, McLeod HL. Strategies for enzyme/prodrug cancer therapy. Clin Cancer Res. 2001 Nov;7(11):3314-24. PMID:11705842
  16. Lippow SM, Wittrup KD, Tidor B. Computational design of antibody-affinity improvement beyond in vivo maturation. Nat Biotechnol. 2007 Oct;25(10):1171-6. Epub 2007 Sep 23. PMID:17891135 doi:10.1038/nbt1336
  17. Gribenko AV, Patel MM, Liu J, McCallum SA, Wang C, Makhatadze GI. Rational stabilization of enzymes by computational redesign of surface charge-charge interactions. Proc Natl Acad Sci U S A. 2009 Feb 5. PMID:19196981
  18. Ducancel F, Muller BH. Molecular engineering of antibodies for therapeutic and diagnostic purposes. MAbs. 2012 Jul-Aug;4(4):445-57. doi: 10.4161/mabs.20776. Epub 2012 Jul 1. PMID:22684311 doi:
Personal tools